Mechanism for the cardioprotective effects of the calcium channel blocker clentiazem during ischemia and reperfusion

Japanese Circulation Journal

Volumn 62, Issue 8, 1998, Pages 611-616

  Kusuoka, Hideo ^a   Corretti, Mary C ^b   Koretsune, Yukihiro ^c   Marban, Eduardo ^d  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium channel blocker; Intracellular Ca2+ concentration; Nuclear magnetic resonance; Stunned myocardium

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CLENTIAZEM;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR SPACE; FERRET; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RECEPTOR AFFINITY; REPERFUSION INJURY;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; FERRETS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY;

EID: 0031858548     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.611     Document Type: Article

References (24)

1. Heusch G: Myocardial stunning: a role for calcium antagonists during ischemia? Cardiovasc Res 1992; 26: 14-19
2. 2+ and heart function after ischemia. Am J Physiol 1980; 238: H909-H916
3. 2+ antagonists. J Mol Cell Cardiol 1986; 18(Suppl 4): 71-75
4. Higgins AJ, Blackburn KJ: Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J Mol Cell Cardiol 1984; 16: 427-738
5. Ferrari R, Albertini A, Curello S, Ceconi C, Di Lisa F, Raddino R, Visioli O: Myocardial recovery during post-ischemic reperfusion: effects of nifedipine, calcium and magnesium. J Mol Cell Cardiol 1986; 18: 487-498
6. Kusuoka H, Marban E: Cellular mechanisms of myocardial stunning. Ann Rev Physiol 1992; 54: 243-56
7. Watts JA, Norris TA, London RE, Steenbergen C, Murphy E: Effects of diltiazem on lactate, ATP, cytosolic free calcium levels in ischemic hearts. J Cardiovasc Pharmacol 1990; 15: 44-49
8. Davies NJ, McVeigh JJ, Lopaschuk GD: Effects of TA-3090, a new calcium channel blocker, on myocardial substrate utilization in ischemic and nonischemic isolated working fatty acid-perfused rat hearts. Circ Res 1991; 68: 807-817
9. Rousseau G, Provost P, Latour JG: Sustained myocardial protection by clentiazem (TA-3090) after a 90-minute coronary occlusion and 72 hours of reperfusion in dogs with collateral flow. J Cardiovasc Pharmacol 1993; 22: 264-272
10. Tanguay M, Lepage G, Blaise G, Garceau D, Dumont L: Clentiazem, diltiazem, and cold cardioplegia in isolated ischemic rabbit hearts: relation between additive cardioprotection, physicochemical properties, and preservation of myocardial lipid components. J Cardiovasc Pharmacol 1994; 24: 950-959
11. Kikkawa K, Yamauchi R, Suzuki T, Banno K, Murata S, Tetsuka T, Nagao T: Effects of clentiazem on cerebral ischemia induced by carotid artery occlusion in stroke-prone spontaneously hypertensive rats. Stroke 1994; 25: 474-480
12. 3H]TA-4090, a selective benzothiazepine-type calcium channel receptor antagonist: In vitro characterization. J Pharmacol Exp Ther 1990; 253: 461-465
13. 2+-activated force by inorganic phosphate. Circ Res 1986; 59: 270-282
14. 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci USA 1987; 84: 6005-6009
15. 2+]i in perfused hearts: critical evaluation of the 5F-BAPTA/NMR method as applied to the study of ischemia and reperfusion. Circ Res 1990; 66: 1255-1267
16. 19F NMR of fluorine-labeled chelators. Proc Natl Acad Sci USA 1983; 80: 7178-7182
17. 19F NMR spectroscopy. Circ Res 1988; 63: 673-678
18. Kusuoka H, Inoue M, Tsuneoka Y, Watari H, Hori M, Abe H: Augmented energy consumption during early systole as a mechanism of cyclical changes in high-energy phosphates in myocardium assessed by phosphorus nuclear magnetic resonance. Jpn Circ J 1985; 49: 1099-1107
19. Allen DG, Morris PG, Orchard CH, Pirolo JS: A nuclear magnetic resonance study of metabolism in the ferret heart during hypoxia and inhibition of glycolysis. J Physiol (Lond) 1985; 361: 185-204
20. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 1987; 79: 950-961
21. 2+ homeostasis in hearts reperfused after prolonged episodes of ischemia. Ann NY Acad Sci 1994; 723: 38-50
22. 19F nuclear magnetic resonance. In: Pohost GM, editor. Cardiovascular applications of magnetic resonance. New York: Futura, 1993; 393-401
23. Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA, Nefedipine administered after reperfusion ablates contractile dysfunction of postischemic "stunnd" myocardium. J Am Coll Cardiol 1989; 13: 1176-1183
24. Przyklenk K, Kloner RA, Effect of verapamil on postischemic "stunned" myocardium: importance of the timing of treatment. J Am Coll Cardiol 1988; 11: 614-623